Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. The past few decades have witnessed widespread research to challenge carcinogenesis; however, it remains one of the most important health concerns with the worst prognosis and diagnosis. Increasing lines of evidence clearly show that the rate...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
MDPI AG
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/73030 |
| _version_ | 1848762905363742720 |
|---|---|
| author | Ranaware, A. Banik, K. Deshpande, V. Padmavathi, G. Roy, N. Sethi, G. Fan, L. Kumar, Alan Prem Kunnumakkara, A. |
| author_facet | Ranaware, A. Banik, K. Deshpande, V. Padmavathi, G. Roy, N. Sethi, G. Fan, L. Kumar, Alan Prem Kunnumakkara, A. |
| author_sort | Ranaware, A. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | © 2018 by the authors. Licensee MDPI, Basel, Switzerland. The past few decades have witnessed widespread research to challenge carcinogenesis; however, it remains one of the most important health concerns with the worst prognosis and diagnosis. Increasing lines of evidence clearly show that the rate of cancer incidence will increase in future and will create global havoc, designating it as an epidemic. Conventional chemotherapeutics and treatment with synthetic disciplines are often associated with adverse side effects and development of chemoresistance. Thus, discovering novel economic and patient friendly drugs that are safe and efficacious is warranted. Several natural compounds have proved their potential against this dreadful disease so far. Magnolol is a hydroxylated biphenyl isolated from the root and stem bark of Magnolia tree. Magnolol can efficiently prevent or inhibit the growth of various cancers originating from different organs such as brain, breast, cervical, colon, liver, lung, prostate, skin, etc. Considering these perspectives, the current review primarily focuses on the fascinating role of magnolol against various types of cancers, and the source and chemistry of magnolol and the molecular mechanism underlying the targets of magnolol are discussed. This review proposes magnolol as a suitable candidate that can be appropriately designed and established into a potent anti-cancer drug. |
| first_indexed | 2025-11-14T10:54:59Z |
| format | Journal Article |
| id | curtin-20.500.11937-73030 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T10:54:59Z |
| publishDate | 2018 |
| publisher | MDPI AG |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-730302021-01-08T07:54:27Z Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer Ranaware, A. Banik, K. Deshpande, V. Padmavathi, G. Roy, N. Sethi, G. Fan, L. Kumar, Alan Prem Kunnumakkara, A. © 2018 by the authors. Licensee MDPI, Basel, Switzerland. The past few decades have witnessed widespread research to challenge carcinogenesis; however, it remains one of the most important health concerns with the worst prognosis and diagnosis. Increasing lines of evidence clearly show that the rate of cancer incidence will increase in future and will create global havoc, designating it as an epidemic. Conventional chemotherapeutics and treatment with synthetic disciplines are often associated with adverse side effects and development of chemoresistance. Thus, discovering novel economic and patient friendly drugs that are safe and efficacious is warranted. Several natural compounds have proved their potential against this dreadful disease so far. Magnolol is a hydroxylated biphenyl isolated from the root and stem bark of Magnolia tree. Magnolol can efficiently prevent or inhibit the growth of various cancers originating from different organs such as brain, breast, cervical, colon, liver, lung, prostate, skin, etc. Considering these perspectives, the current review primarily focuses on the fascinating role of magnolol against various types of cancers, and the source and chemistry of magnolol and the molecular mechanism underlying the targets of magnolol are discussed. This review proposes magnolol as a suitable candidate that can be appropriately designed and established into a potent anti-cancer drug. 2018 Journal Article http://hdl.handle.net/20.500.11937/73030 10.3390/ijms19082362 http://creativecommons.org/licenses/by/4.0/ MDPI AG fulltext |
| spellingShingle | Ranaware, A. Banik, K. Deshpande, V. Padmavathi, G. Roy, N. Sethi, G. Fan, L. Kumar, Alan Prem Kunnumakkara, A. Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer |
| title | Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer |
| title_full | Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer |
| title_fullStr | Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer |
| title_full_unstemmed | Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer |
| title_short | Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer |
| title_sort | magnolol: a neolignan from the magnolia family for the prevention and treatment of cancer |
| url | http://hdl.handle.net/20.500.11937/73030 |